News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
162,450 Results
Type
Article (3721)
Company Profile (98)
Press Release (158631)
Multimedia
Podcasts (1)
Webinars (3)
Section
Business (50057)
Career Advice (101)
Deals (8744)
Drug Delivery (4)
Drug Development (30755)
Employer Resources (13)
FDA (2735)
Job Trends (3439)
News (90952)
Policy (5948)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (4)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (3)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (207)
Accelerated approval (1)
Allergies (29)
Alliances (11514)
ALS (31)
Alzheimer's disease (337)
Antibody-drug conjugate (ADC) (40)
Approvals (2791)
Artificial intelligence (47)
Autoimmune disease (8)
Automation (1)
Bankruptcy (51)
Best Places to Work (3068)
BIOSECURE Act (2)
Biosimilars (28)
Biotechnology (67)
Bladder cancer (31)
Brain cancer (12)
Breast cancer (69)
Cancer (722)
Cardiovascular disease (46)
Career advice (92)
Career pathing (2)
CAR-T (54)
Cell therapy (121)
Cervical cancer (7)
Clinical research (26521)
Collaboration (239)
Compensation (288)
Complete response letters (3)
COVID-19 (382)
CRISPR (8)
C-suite (92)
Cystic fibrosis (20)
Data (839)
Depression (12)
Diabetes (63)
Diagnostics (448)
Diversity, equity & inclusion (3)
Drug discovery (27)
Drug pricing (3)
Drug shortages (2)
Duchenne muscular dystrophy (16)
Earnings (22063)
Editorial (2)
Employer branding (1)
Employer resources (12)
Events (32872)
Executive appointments (268)
FDA (3097)
Featured Employer (17)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (184)
Gene editing (19)
Generative AI (1)
Gene therapy (47)
GLP-1 (144)
Government (434)
Grass and pollen (2)
Guidances (13)
Healthcare (2121)
Huntington's disease (5)
IgA nephropathy (7)
Immunology and inflammation (26)
Indications (16)
Infectious disease (406)
Inflammatory bowel disease (44)
Influenza (8)
Intellectual property (31)
Interviews (12)
IPO (5374)
IRA (2)
Job creations (531)
Job search strategy (86)
Kidney cancer (5)
Layoffs (34)
Legal (734)
Liver cancer (15)
Lung cancer (113)
Lymphoma (63)
Machine learning (1)
Management (4)
Manufacturing (77)
MASH (32)
Medical device (673)
Medtech (673)
Mergers & acquisitions (3587)
Metabolic disorders (177)
Multiple sclerosis (29)
NASH (8)
Neurodegenerative disease (19)
Neuropsychiatric disorders (2)
Neuroscience (496)
NextGen: Class of 2025 (809)
Non-profit (259)
Northern California (1113)
Now hiring (3)
Obesity (79)
Opinion (23)
Ovarian cancer (32)
Pain (21)
Pancreatic cancer (21)
Parkinson's disease (42)
Patents (63)
Patient recruitment (45)
Peanut (16)
People (15872)
Pharmaceutical (32)
Phase I (7861)
Phase II (12079)
Phase III (8705)
Pipeline (447)
Policy (7)
Postmarket research (496)
Preclinical (2892)
Press Release (11)
Prostate cancer (26)
Psychedelics (8)
Radiopharmaceuticals (100)
Rare diseases (85)
Real estate (981)
Recruiting (7)
Regulatory (5290)
Reports (8)
Research institute (239)
Resumes & cover letters (6)
RSV (6)
Schizophrenia (36)
Series A (33)
Series B (23)
Service/supplier (2)
Sickle cell disease (6)
Southern California (874)
Spinal muscular atrophy (41)
Sponsored (2)
Startups (816)
State (1)
Supply chain (11)
Tariffs (2)
The Weekly (1)
United States (7971)
Vaccines (98)
Venture capitalists (2)
Weight loss (16)
Women's health (1)
Date
Today (78)
Last 7 days (268)
Last 30 days (849)
Last 365 days (11106)
2025 (3478)
2024 (11818)
2023 (13424)
2022 (15425)
2021 (16993)
2020 (14550)
2019 (9607)
2018 (6851)
2017 (8597)
2016 (7046)
2015 (8865)
2014 (6628)
2013 (4730)
2012 (4719)
2011 (4675)
2010 (4622)
Location
Africa (86)
Alabama (15)
Arizona (23)
Arkansas (2)
Asia (12169)
Australia (1396)
California (2328)
Canada (507)
China (295)
Colorado (66)
Connecticut (87)
Delaware (75)
Europe (23086)
Florida (275)
Georgia (69)
Idaho (4)
Illinois (94)
India (7)
Indiana (67)
Iowa (2)
Japan (40)
Kansas (51)
Kentucky (7)
Maine (2)
Maryland (221)
Massachusetts (1766)
Michigan (35)
Minnesota (79)
Missouri (13)
Montana (1)
Nebraska (5)
Nevada (6)
New Hampshire (4)
New Jersey (810)
New Mexico (7)
New York (787)
North Carolina (332)
Northern California (1113)
Ohio (63)
Oklahoma (3)
Oregon (12)
Pennsylvania (393)
Puerto Rico (1)
Rhode Island (4)
South America (135)
Southern California (874)
Tennessee (10)
Texas (217)
Utah (40)
Virginia (45)
Washington D.C. (9)
Washington State (129)
Wisconsin (9)
162,450 Results for "paradigm biopharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cybin Announces Additional Strategic Clinical Site Partnerships to Support PARADIGM, a Multinational Phase 3 Program Evaluating CYB003
April 23, 2025
·
7 min read
Press Releases
Axsome Therapeutics Announces Topline Results of PARADIGM Phase 3 Proof-of-Concept Trial of Solriamfetol in Major Depressive Disorder (MDD) with and without Excessive Daytime Sleepiness (EDS)
April 1, 2025
·
7 min read
Press Releases
Icotrokinra meets primary endpoint of clinical response in ulcerative colitis study and shows potential to transform the treatment paradigm for patients
March 10, 2025
·
9 min read
Press Releases
Icotrokinra Clinical Study Results Demonstrate Its Potential to Shift Treatment Paradigm and Set a New Standard for Treatment in Plaque Psoriasis
March 10, 2025
·
16 min read
Press Releases
Hengrui’s Camrelizumab Combo Therapy Doubles the Five -Year Survival of Patients with Advanced Squamous Lung Cancer - A Potential Paradigm Shift in Clinical Outcome for this Difficult-to Treat Population
April 1, 2025
·
2 min read
Press Releases
Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis
March 11, 2025
·
10 min read
Press Releases
PESG Report: Silexion Therapeutics’ Breakthrough Data Shows SIL204’s impact on both Primary Tumors & Metastasis – Signaling a Potential Paradigm Shift in Cancer Treatment
March 17, 2025
·
4 min read
BioMidwest
Paradigm and Altru Health System Expand Patient Access to Clinical Trials for Rural Population
Paradigm announced results from a collaboration with Altru Health System (Altru) to improve the efficiency of its clinical research program and expand the availability of clinical research as a care option for patients spanning 46 locations across a rural catchment area of over 4,000 square miles in North Dakota and Minnesota.
May 29, 2024
·
4 min read
Press Releases
Hyundai ADM Unveils a “New Paradigm in Cancer Treatment” - Preclinical Study Shows Promise for Continuous Oral Chemotherapy with Lowered Side Effects Risks
January 22, 2025
·
4 min read
Drug Development
Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
Axsome Therapeutics, Inc. announced the first patient has been dosed in the PARADIGM Phase 3 trial of solriamfetol, an investigational treatment for major depressive disorder.
March 19, 2024
·
5 min read
1 of 16,245
Next
